Publications
Filters: Keyword is Humans [Clear All Filters]
“Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure”, Am J Trop Med Hyg, vol. 102, no. 1, pp. 147-150, 2020.
, “International gestational age-specific centiles for umbilical artery Doppler indices: a longitudinal prospective cohort study of the INTERGROWTH-21(st) Project”, Am J Obstet Gynecol, vol. 222, no. 6, pp. 602 e1-602 e15, 2020.
, “Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria”, J Infect Dis, vol. 219, no. 9, pp. 1483-1489, 2019.
, “Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis”, BMC Med, vol. 17, no. 1, p. 1, 2019.
, “Comparative 3D genome organization in apicomplexan parasites”, Proc Natl Acad Sci U S A, vol. 116, no. 8, pp. 3183-3192, 2019.
, “Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis”, Malar J, vol. 18, no. 1, p. 225, 2019.
, “Image-scoring system for umbilical and uterine artery pulsed-wave Doppler ultrasound measurement”, Ultrasound Obstet Gynecol, vol. 53, no. 2, pp. 251-255, 2019.
, “The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial”, PLoS Med, vol. 16, no. 2, p. e1002745, 2019.
, “Maternal Hepatitis B Infection Burden, Comorbidity and Pregnancy Outcome in a Low-Income Population on the Myanmar-Thailand Border: A Retrospective Cohort Study”, J Pregnancy, vol. 2019, p. 8435019, 2019.
, “New malaria maps”, Lancet, vol. 394, no. 10195, pp. 278-279, 2019.
, “Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children”, Nat Commun, vol. 10, no. 1, p. 480, 2019.
, “Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia”, Malar J, vol. 18, no. 1, p. 114, 2019.
, “The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar”, Malar J, vol. 18, no. 1, p. 50, 2019.
, “Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015)”, Malar J, vol. 18, no. 1, p. 240, 2019.
, “The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density”, Nat Commun, vol. 10, no. 1, p. 1433, 2019.
, “Antimalarial drugs for treating and preventing malaria in pregnant and lactating women”, Expert Opin Drug Saf, vol. 17, no. 11, pp. 1129-1144, 2018.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, vol. 100, no. 3, pp. 294-303, 2018.
, “A new highly sensitive enzyme-linked immunosorbent assay for the detection of Plasmodium falciparum histidine-rich protein 2 in whole blood”, Malar J, vol. 17, no. 1, p. 403, 2018.
, “The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background”, Nat Commun, vol. 9, no. 1, p. 5158, 2018.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria”, Malar J, vol. 16, no. 1, p. 134, 2017.
, “Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border”, J Infect Dis, vol. 215, no. 3, pp. 396-404, 2017.
, “Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?”, Expert Opin Drug Saf, vol. 15, no. 3, pp. 367-82, 2016.
, “Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance”, Science, vol. 347, no. 6220, pp. 431-5, 2015.
, “Exploitation and community engagement: can community advisory boards successfully assume a role minimising exploitation in international research?”, Dev World Bioeth, vol. 15, no. 1, pp. 18-26, 2015.
, “Genetic architecture of artemisinin-resistant Plasmodium falciparum”, Nat Genet, vol. 47, no. 3, pp. 226-34, 2015.
, “Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia”, J Infect Dis, vol. 211, no. 5, pp. 670-9, 2015.
, “Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects”, Am J Trop Med Hyg, vol. 92, no. 1, pp. 22-7, 2015.
, “Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests”, Am J Trop Med Hyg, vol. 92, no. 4, pp. 818-24, 2015.
, “Dense genomic sampling identifies highways of pneumococcal recombination”, Nat Genet, vol. 46, no. 3, pp. 305-9, 2014.
, “Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast”, Infect Immun, vol. 82, no. 3, pp. 1296-1307, 2014.
, “PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation”, J Infect Dis, vol. 209, no. 11, pp. 1808-15, 2014.
, “Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine”, Am J Trop Med Hyg, vol. 91, no. 4, pp. 833-43, 2014.
, “Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda”, J Antimicrob Chemother, vol. 69, no. 11, pp. 3033-40, 2014.
, “Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species”, J Infect Dis, vol. 210, no. 10, pp. 1616-26, 2014.
, “Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3”, PLoS ONE, vol. 8, no. 2, p. e56061, 2013.
, “Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria”, Clin Infect Dis, vol. 56, no. 5, pp. e48-58, 2013.
, “Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing”, PLoS ONE, vol. 8, no. 1, p. e53160, 2013.
, “Malaria in the post-partum period; a prospective cohort study”, PLoS ONE, vol. 8, no. 3, p. e57890, 2013.
, “Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants”, J Infect Dis, vol. 207, no. 11, pp. 1646-54, 2013.
, “Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture”, Int J Parasitol, vol. 42, no. 2, pp. 155-60, 2012.
, “Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010”, PLoS ONE, vol. 7, no. 7, p. e40244, 2012.
, “The epidemiology of postpartum malaria: a systematic review”, Malar J, vol. 11, p. 114, 2012.
, “Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp”, Eur J Nutr, vol. 51, no. 4, pp. 425-34, 2012.
, “Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria”, Antimicrob Agents Chemother, vol. 56, no. 4, pp. 1997-2007, 2012.
, “Pyronaridine-artesunate versus mefloquine plus artesunate for malaria”, N Engl J Med, vol. 366, no. 14, pp. 1298-309, 2012.
, “Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study”, PLoS ONE, vol. 7, no. 4, p. e34018, 2012.
, “Ultrasound evidence of early fetal growth restriction after maternal malaria infection”, PLoS ONE, vol. 7, no. 2, p. e31411, 2012.
, “Barriers to immunization among children of migrant workers from Myanmar living in Tak province, Thailand”, Bull World Health Organ, vol. 89, no. 7, pp. 528-31, 2011.
, “Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand”, Malar J, vol. 10, p. 113, 2011.
, “Intrahost modeling of artemisinin resistance in Plasmodium falciparum”, Proc Natl Acad Sci U S A, vol. 108, no. 1, pp. 397-402, 2011.
, “Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax”, J Infect Dis, vol. 203, no. 2, pp. 207-10, 2011.
, “Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance”, PLoS ONE, vol. 6, no. 5, p. e20212, 2011.
, “Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria”, Antimicrob Agents Chemother, vol. 55, no. 9, pp. 4338-42, 2011.
, “A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage”, BMC Infect Dis, vol. 11, p. 108, 2011.
, “A research agenda for malaria eradication: drugs”, PLoS Med, vol. 8, no. 1, p. e1000402, 2011.
, “Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review”, Trop Med Int Health, vol. 16, no. 2, pp. 145-51, 2011.
, “Artemisinin combination therapy for vivax malaria”, Lancet Infect Dis, vol. 10, no. 6, pp. 405-16, 2010.
, “First report of an Orientia tsutsugamushi type TA716-related scrub typhus infection in Thailand”, Vector Borne and Zoonotic Diseases, vol. 10, no. 2, pp. 191-3, 2010.
, “Malaria in children”, Lancet, vol. 375, no. 9724, pp. 1468-81, 2010.
, “Pyronaridine-artesunate for uncomplicated falciparum malaria”, Lancet, vol. 375, no. 9724, pp. 1413-4, 2010.
, “Antimalarial therapies in children from Papua New Guinea”, N Engl J Med, vol. 360, no. 12, p. 1254; author reply 1255, 2009.
, “Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood”, Malar J, vol. 8, p. 115, 2009.
, “Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis”, Malar J, vol. 8, p. 203, 2009.
, “Multiple displacement amplification for malaria parasite DNA”, J Parasitol, vol. 95, no. 1, pp. 253-5, 2009.
, “The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria”, Malar J, vol. 8, p. 207, 2009.
, “Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria”, Antimicrob Agents Chemother, vol. 53, no. 9, pp. 3837-46, 2009.
, “Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar”, Trop Med Int Health, vol. 13, no. 1, pp. 91-8, 2008.
, “Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum”, Antimicrob Agents Chemother, vol. 52, no. 7, pp. 2435-41, 2008.
, “Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms”, PLoS ONE, vol. 2, no. 10, p. e1089, 2007.
, “Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria”, Am J Trop Med Hyg, vol. 77, no. 3, pp. 447-50, 2007.
, “How much fat is necessary to optimize lumefantrine oral bioavailability?”, Trop Med Int Health, vol. 12, no. 2. pp. 195-200, 2007.
, “In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border”, Malar J, vol. 6, p. 81, 2007.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs”, Malar J, vol. 6, p. 119, 2007.
, “Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative”, PLoS Med, vol. 3, no. 6, p. e183, 2006.
, “Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison”, Lancet, vol. 367, no. 9528, pp. 2075-85, 2006.
, “Manslaughter by fake artesunate in Asia--will Africa be next?”, PLoS Med, vol. 3, no. 6, p. e197, 2006.
, “The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, vol. 62, no. 12, pp. 1021-31, 2006.
, “Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 50, no. 7, pp. 2281-5, 2006.
, “Toxic brainstem encephalopathy after artemisinin treatment for breast cancer”, Ann Neurol, vol. 59, no. 4, pp. 725-6, 2006.
, “We still need artesunate monotherapy”, BMJ, vol. 333, no. 7557, p. 45, 2006.
, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial”, Lancet, vol. 366, no. 9487, pp. 717-25, 2005.
, “Malaria misconceptions”, Lancet, vol. 365, no. 9460, p. 653, 2005.
, “Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria”, Antimicrob Agents Chemother, vol. 49, no. 4, pp. 1622-5, 2005.
, “Artesunate combinations for treatment of malaria: meta-analysis”, Lancet, vol. 363, no. 9402. pp. 9-17, 2004.
, “Trichuris trichiura infection is associated with the multiplicity of Plasmodium falciparum infections, in Thailand”, Ann Trop Med Parasitol, vol. 97, no. 2, pp. 199-202, 2003.
, “Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission”, Am J Epidemiol, vol. 154, no. 5, pp. 459-65, 2001.
, “Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study”, Lancet, vol. 356, no. 9226, pp. 297-302, 2000.
, “Prophylactic effect of Malarone against malaria: all good news?”, Lancet, vol. 356, no. 9245, pp. 1864-5, 2000.
, “Assessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction”, Mol Biochem Parasitol, vol. 85, no. 2, pp. 161-9, 1997.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
,